-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Up 5%
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Up 5%
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating)'s stock price traded up 5% during mid-day trading on Thursday . The company traded as high as $0.71 and last traded at $0.63. 2,926 shares traded hands during trading, a decline of 36% from the average session volume of 4,598 shares. The stock had previously closed at $0.60.
ZIVO Bioscience Trading Up 5.0 %
The business has a fifty day moving average price of $0.77 and a 200-day moving average price of $0.73.
Get ZIVO Bioscience alerts:Institutional Trading of ZIVO Bioscience
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its stake in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,654 shares of the company's stock after purchasing an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
About ZIVO Bioscience
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Featured Stories
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating)'s stock price traded up 5% during mid-day trading on Thursday . The company traded as high as $0.71 and last traded at $0.63. 2,926 shares traded hands during trading, a decline of 36% from the average session volume of 4,598 shares. The stock had previously closed at $0.60.
ZIVO Bioscience, Inc.（纳斯达克股票代码：ZIVOW — 获取评级）的股价在周四午盘交易中上涨了5％。该公司的交易价格高达0.71美元，最后一次交易价格为0.63美元。交易期间交易了2,926股，较平均交易量4598股下降了36％。该股此前收于0.60美元。
ZIVO Bioscience Trading Up 5.0 %
ZIVO Bioscience 交易上涨5.0％
The business has a fifty day moving average price of $0.77 and a 200-day moving average price of $0.73.
该企业的五十天移动平均价格为0.77美元，200天移动平均价格为0.73美元。
Institutional Trading of ZIVO Bioscience
ZIVO 生物科学的机构交易
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its stake in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,654 shares of the company's stock after purchasing an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
一位机构投资者最近提高了其在ZIVO Bioscience股票中的头寸。根据向美国证券交易委员会（SEC）提交的最新文件，Warberg Asset Management LLC在第三季度将其在ZIVO Bioscience, Inc.（纳斯达克股票代码：ZIVOW — 获取评级）的股份增加了442.0％。该基金在此期间又购买了69,034股股票后，拥有该公司84,654股股票。截至最近报告期末，Warberg Asset Management LLC在ZIVO Bioscience的持股价值51,000美元。
About ZIVO Bioscience
关于 ZIVO 生物科学
(Get Rating)
（获取评分）
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc 是一家总部位于密歇根州的生物技术/农业科技公司，致力于利用其专有藻类培养物的生物活性化合物的免疫健康和营养益处。开发渠道包括用作膳食补充剂和功能性食品原料的天然产品，以及旨在为人类和动物提供药物和药物功效的创新、生物衍生和合成的候选产品，特别侧重于调节免疫和炎症反应。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
- 免费获取 StockNews.com 关于 ZIVO Bioscience (ZIVOW) 的研究报告的副本
- Hypercharge Networks：上涨了三位数，但有什么大不了的？
- 苹果30％的涨势有长足的3个原因
- 选择原住民而不是第一共和国银行的3个理由
- 4月3日财报为看涨的波段交易者带来了乐观
- 星座品牌之星即将崛起吗？
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 ZIVO 生物科学日报的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收ZIVO Bioscience及相关公司最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧